BioLineRx (BLRX) Shares Outstanding (Diluted) (2022 - 2026)
BioLineRx's Shares Outstanding (Diluted) was 2.47 billion in the quarter ended Jun 30, 2026, up 105.8% from 1.2 billion a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends
From the quarter ended Dec 31, 2015 onward, BioLineRx has reported Shares Outstanding (Diluted) for 43 quarters.
- Shares Outstanding (Diluted) has now increased for ten consecutive years, with a five-year compound annual growth rate of 57.7% (years ended Dec 2020 to Dec 2025).
- In earlier years, Shares Outstanding (Diluted) was 1.2 billion in the year ended Dec 31, 2024 (+24.4%), 963.37 million in the year ended Dec 31, 2023 (+24.5%), 773.96 million in the year ended Dec 31, 2022 (+16.7%) and 662.93 million in the year ended Dec 31, 2021 (+162.2%).
- Compared with a year earlier, Shares Outstanding (Diluted) has increased for 39 straight quarters, with growth averaging 54.9% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Diluted) ran from 16.7% in the quarter ended Dec 31, 2022 to 162.2% in the quarter ended Sep 30, 2022.
- Per Business Quant data, BLRX's Shares Outstanding (Diluted) in the three quarters before the quarter ended Jun 30, 2026 was 2.47 billion (quarter ended Mar 31, 2026), 2.47 billion (quarter ended Dec 31, 2025) and 1.2 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 5.75 Bn |
| 10 | BioLineRx | 6.74 Mn | -69.78 Mn | 235,000.00 | 4.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.11 Mn |
| Mar 31, 2026 | 4.11 Mn |
| Dec 31, 2025 | 4.11 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 1.61 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Mar 31, 2024 | 1.61 Mn |
| Dec 31, 2023 | 1.61 Mn |
| Sep 30, 2023 | 578,522.34 |
| Jun 30, 2023 | 578,522.34 |
| Mar 31, 2023 | 578,522.34 |
| Dec 31, 2022 | 578,522.34 |
API Access
BioLineRx Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();